Cargando…
The glucocorticoid receptor signalling in breast cancer
Glucocorticoids (GCs) are provided as co-medication with chemotherapy in breast cancer, albeit several lines of evidence indicate that their use may have diverse effects and in fact may inhibit chemosensitivity. The molecular basis of GC-induced resistance to chemotherapy in breast cancer remains po...
Autores principales: | Moutsatsou, Paraskevi, Papavassiliou, Athanasios G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823477/ https://www.ncbi.nlm.nih.gov/pubmed/18053085 http://dx.doi.org/10.1111/j.1582-4934.2007.00177.x |
Ejemplares similares
-
Glucocorticoid Receptor Signaling in Diabetes
por: Kokkinopoulou, Ioanna, et al.
Publicado: (2021) -
Mitochondrial Glucocorticoid Receptors and Their Actions
por: Kokkinopoulou, Ioanna, et al.
Publicado: (2021) -
Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives
por: Papavassiliou, Kostas A., et al.
Publicado: (2023) -
Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
por: Anestis, Aristomenis, et al.
Publicado: (2020) -
Glucose can promote a glucocorticoid resistance state
por: Kassi, Eva, et al.
Publicado: (2012)